Issi Rozen is a Venture Partner at GV, where he primarily focuses on the formation of new companies and early-stage investments. Issi is an experienced biotech executive and a serial entrepreneur who co-founded multiple startups, including GV portfolio company Verve Therapeutics.
Previously, Issi spent a decade at the Broad Institute of MIT and Harvard, where he was the Institute’s first Chief Business Officer and a member of the Executive Leadership Team. At the Broad, Issi led the creation of the Office of Strategic Alliances and Partnering and was responsible for developing innovative scientific and business collaborations, initiating and establishing new ventures around novel technologies, and overseeing strategy and licensing of the Institute’s intellectual property portfolio. Issi played a key role in the creation and spin-out of over 20 startups from the Institute. Prior to joining the Broad, Issi led strategy and business development efforts at a number of biotech companies.
An accomplished jazz guitarist, Issi is also a former professor at Berklee College of Music. He earned his M.B.A. at MIT’s Sloan School of Management.